NCT01529307View on ClinicalTrials.gov

First in Human Trial of TAS266 in Patients With Advanced Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Advanced Solid Tumors
Interventions
DRUG

TAS266

TAS266 IV infusions given weekly

Trial Locations (3)

33612

H. Lee Moffitt Cancer Center/University of South Florida Moffitt SC, Tampa

84103

University of Utah / Huntsman Cancer Institute Huntsman UT, Salt Lake City

789229

South Texas Accelerated Research Therapeutics START, San Antonio

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY